rdf:type |
|
lifeskim:mentions |
umls-concept:C0021368,
umls-concept:C0026682,
umls-concept:C0026809,
umls-concept:C0039194,
umls-concept:C0205314,
umls-concept:C0441712,
umls-concept:C0458827,
umls-concept:C0679622,
umls-concept:C0851285,
umls-concept:C1155263,
umls-concept:C1514562,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
7
|
pubmed:dateCreated |
2006-9-19
|
pubmed:abstractText |
The development of asthma and other atopic diseases is influenced by cytokines produced by Th2 effector T cells. How effector T cell responses are regulated once these cell populations are established remains unclear. The recently described T cell and airway phenotype regulator locus, containing the T cell, Ig domain, mucin domain (TIM) genes, is genetically associated with Th2 cytokine production and Th2-dependent immune responses. In this study, we report the phenotype of the TIM-2 gene-deficient mouse, and demonstrate exacerbated lung inflammation in an airway atopic response model. Immune responses in the TIM-2-deficient mouse reveal disregulated expression of Th2 cytokines, and adoptive transfer experiments show that the T cell compartment is responsible for the heightened inflammatory phenotype. These studies show that TIM-2 is a novel and critical regulator of effector T cell activity.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author |
pubmed-author:BaillyVeroniqueV,
pubmed-author:BonventreJoseph VJV,
pubmed-author:IchimuraTakaharuT,
pubmed-author:LiZhifangZ,
pubmed-author:McCoonPatriciaP,
pubmed-author:MiklaszStevenS,
pubmed-author:PabloLourdesL,
pubmed-author:RennardRachelR,
pubmed-author:RennertPaul DPD,
pubmed-author:SizingIrene DID,
pubmed-author:TarilonteLeticiaL
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4311-21
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16982865-Animals,
pubmed-meshheading:16982865-Asthma,
pubmed-meshheading:16982865-Cell Differentiation,
pubmed-meshheading:16982865-Disease Models, Animal,
pubmed-meshheading:16982865-Flow Cytometry,
pubmed-meshheading:16982865-Inflammation,
pubmed-meshheading:16982865-Lung,
pubmed-meshheading:16982865-Membrane Proteins,
pubmed-meshheading:16982865-Mice,
pubmed-meshheading:16982865-Mice, Inbred BALB C,
pubmed-meshheading:16982865-Mice, Mutant Strains,
pubmed-meshheading:16982865-Ovalbumin,
pubmed-meshheading:16982865-Rats,
pubmed-meshheading:16982865-Recombinant Fusion Proteins,
pubmed-meshheading:16982865-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16982865-T-Lymphocytes,
pubmed-meshheading:16982865-Th2 Cells
|
pubmed:year |
2006
|
pubmed:articleTitle |
T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation.
|
pubmed:affiliation |
Biogen-Idec, 12 Cambridge Center, Cambridge, MA 01746, USA. paul.rennert@biogenidec.com
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|